BIOMAT Database Logo BIOMAT Database Logo

Immune activation alters cellular and humoral responses to yellow fever 17D vaccine. 2014

Enoch Muyanja, and Aloysius Ssemaganda, and Pearline Ngauv, and Rafael Cubas, and Helene Perrin, and Divya Srinivasan, and Glenda Canderan, and Benton Lawson, and Jakub Kopycinski, and Amanda S Graham, and Dawne K Rowe, and Michaela J Smith, and Sharon Isern, and Scott Michael, and Guido Silvestri, and Thomas H Vanderford, and Erika Castro, and Giuseppe Pantaleo, and Joel Singer, and Jill Gillmour, and Noah Kiwanuka, and Annet Nanvubya, and Claudia Schmidt, and Josephine Birungi, and Josephine Cox, and Elias K Haddad, and Pontiano Kaleebu, and Patricia Fast, and Rafick-Pierre Sekaly, and Lydie Trautmann, and Denis Gaucher

BACKGROUND Defining the parameters that modulate vaccine responses in African populations will be imperative to design effective vaccines for protection against HIV, malaria, tuberculosis, and dengue virus infections. This study aimed to evaluate the contribution of the patient-specific immune microenvironment to the response to the licensed yellow fever vaccine 17D (YF-17D) in an African cohort. METHODS We compared responses to YF-17D in 50 volunteers in Entebbe, Uganda, and 50 volunteers in Lausanne, Switzerland. We measured the CD8+ T cell and B cell responses induced by YF-17D and correlated them with immune parameters analyzed by flow cytometry prior to vaccination. RESULTS We showed that YF-17D-induced CD8+ T cell and B cell responses were substantially lower in immunized individuals from Entebbe compared with immunized individuals from Lausanne. The impaired vaccine response in the Entebbe cohort associated with reduced YF-17D replication. Prior to vaccination, we observed higher frequencies of exhausted and activated NK cells, differentiated T and B cell subsets and proinflammatory monocytes, suggesting an activated immune microenvironment in the Entebbe volunteers. Interestingly, activation of CD8+ T cells and B cells as well as proinflammatory monocytes at baseline negatively correlated with YF-17D-neutralizing antibody titers after vaccination. Additionally, memory T and B cell responses in preimmunized volunteers exhibited reduced persistence in the Entebbe cohort but were boosted by a second vaccination. CONCLUSIONS Together, these results demonstrate that an activated immune microenvironment prior to vaccination impedes efficacy of the YF-17D vaccine in an African cohort and suggest that vaccine regimens may need to be boosted in African populations to achieve efficient immunity. BACKGROUND Registration is not required for observational studies. BACKGROUND This study was funded by Canada's Global Health Research Initiative, Defense Threat Reduction Agency, National Institute of Allergy and Infectious Diseases, Bill & Melinda Gates Foundation, and United States Agency for International Development.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Enoch Muyanja, and Aloysius Ssemaganda, and Pearline Ngauv, and Rafael Cubas, and Helene Perrin, and Divya Srinivasan, and Glenda Canderan, and Benton Lawson, and Jakub Kopycinski, and Amanda S Graham, and Dawne K Rowe, and Michaela J Smith, and Sharon Isern, and Scott Michael, and Guido Silvestri, and Thomas H Vanderford, and Erika Castro, and Giuseppe Pantaleo, and Joel Singer, and Jill Gillmour, and Noah Kiwanuka, and Annet Nanvubya, and Claudia Schmidt, and Josephine Birungi, and Josephine Cox, and Elias K Haddad, and Pontiano Kaleebu, and Patricia Fast, and Rafick-Pierre Sekaly, and Lydie Trautmann, and Denis Gaucher
17D Yellow Fever Virus Vaccine.
December 2013, The American journal of tropical medicine and hygiene,
Enoch Muyanja, and Aloysius Ssemaganda, and Pearline Ngauv, and Rafael Cubas, and Helene Perrin, and Divya Srinivasan, and Glenda Canderan, and Benton Lawson, and Jakub Kopycinski, and Amanda S Graham, and Dawne K Rowe, and Michaela J Smith, and Sharon Isern, and Scott Michael, and Guido Silvestri, and Thomas H Vanderford, and Erika Castro, and Giuseppe Pantaleo, and Joel Singer, and Jill Gillmour, and Noah Kiwanuka, and Annet Nanvubya, and Claudia Schmidt, and Josephine Birungi, and Josephine Cox, and Elias K Haddad, and Pontiano Kaleebu, and Patricia Fast, and Rafick-Pierre Sekaly, and Lydie Trautmann, and Denis Gaucher
17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients.
June 2016, The Journal of infection,
Enoch Muyanja, and Aloysius Ssemaganda, and Pearline Ngauv, and Rafael Cubas, and Helene Perrin, and Divya Srinivasan, and Glenda Canderan, and Benton Lawson, and Jakub Kopycinski, and Amanda S Graham, and Dawne K Rowe, and Michaela J Smith, and Sharon Isern, and Scott Michael, and Guido Silvestri, and Thomas H Vanderford, and Erika Castro, and Giuseppe Pantaleo, and Joel Singer, and Jill Gillmour, and Noah Kiwanuka, and Annet Nanvubya, and Claudia Schmidt, and Josephine Birungi, and Josephine Cox, and Elias K Haddad, and Pontiano Kaleebu, and Patricia Fast, and Rafick-Pierre Sekaly, and Lydie Trautmann, and Denis Gaucher
A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.
August 2017, Journal of immunology (Baltimore, Md. : 1950),
Enoch Muyanja, and Aloysius Ssemaganda, and Pearline Ngauv, and Rafael Cubas, and Helene Perrin, and Divya Srinivasan, and Glenda Canderan, and Benton Lawson, and Jakub Kopycinski, and Amanda S Graham, and Dawne K Rowe, and Michaela J Smith, and Sharon Isern, and Scott Michael, and Guido Silvestri, and Thomas H Vanderford, and Erika Castro, and Giuseppe Pantaleo, and Joel Singer, and Jill Gillmour, and Noah Kiwanuka, and Annet Nanvubya, and Claudia Schmidt, and Josephine Birungi, and Josephine Cox, and Elias K Haddad, and Pontiano Kaleebu, and Patricia Fast, and Rafick-Pierre Sekaly, and Lydie Trautmann, and Denis Gaucher
Enhancing Inactivated Yellow Fever 17D Vaccine-Induced Immune Responses in Balb/C Mice Using Alum/CpG.
November 2023, Vaccines,
Enoch Muyanja, and Aloysius Ssemaganda, and Pearline Ngauv, and Rafael Cubas, and Helene Perrin, and Divya Srinivasan, and Glenda Canderan, and Benton Lawson, and Jakub Kopycinski, and Amanda S Graham, and Dawne K Rowe, and Michaela J Smith, and Sharon Isern, and Scott Michael, and Guido Silvestri, and Thomas H Vanderford, and Erika Castro, and Giuseppe Pantaleo, and Joel Singer, and Jill Gillmour, and Noah Kiwanuka, and Annet Nanvubya, and Claudia Schmidt, and Josephine Birungi, and Josephine Cox, and Elias K Haddad, and Pontiano Kaleebu, and Patricia Fast, and Rafick-Pierre Sekaly, and Lydie Trautmann, and Denis Gaucher
[Completed sequences analysis on the Chinese attenuated yellow fever 17D vaccine strain and the WHO standard yellow fever 17D vaccine strain].
April 2009, Zhongguo yi miao he mian yi,
Enoch Muyanja, and Aloysius Ssemaganda, and Pearline Ngauv, and Rafael Cubas, and Helene Perrin, and Divya Srinivasan, and Glenda Canderan, and Benton Lawson, and Jakub Kopycinski, and Amanda S Graham, and Dawne K Rowe, and Michaela J Smith, and Sharon Isern, and Scott Michael, and Guido Silvestri, and Thomas H Vanderford, and Erika Castro, and Giuseppe Pantaleo, and Joel Singer, and Jill Gillmour, and Noah Kiwanuka, and Annet Nanvubya, and Claudia Schmidt, and Josephine Birungi, and Josephine Cox, and Elias K Haddad, and Pontiano Kaleebu, and Patricia Fast, and Rafick-Pierre Sekaly, and Lydie Trautmann, and Denis Gaucher
Does yellow fever 17D vaccine protect against melanoma?
January 2009, Vaccine,
Enoch Muyanja, and Aloysius Ssemaganda, and Pearline Ngauv, and Rafael Cubas, and Helene Perrin, and Divya Srinivasan, and Glenda Canderan, and Benton Lawson, and Jakub Kopycinski, and Amanda S Graham, and Dawne K Rowe, and Michaela J Smith, and Sharon Isern, and Scott Michael, and Guido Silvestri, and Thomas H Vanderford, and Erika Castro, and Giuseppe Pantaleo, and Joel Singer, and Jill Gillmour, and Noah Kiwanuka, and Annet Nanvubya, and Claudia Schmidt, and Josephine Birungi, and Josephine Cox, and Elias K Haddad, and Pontiano Kaleebu, and Patricia Fast, and Rafick-Pierre Sekaly, and Lydie Trautmann, and Denis Gaucher
Stability-related studies on 17D yellow fever vaccine.
January 2000, Microbes and infection,
Enoch Muyanja, and Aloysius Ssemaganda, and Pearline Ngauv, and Rafael Cubas, and Helene Perrin, and Divya Srinivasan, and Glenda Canderan, and Benton Lawson, and Jakub Kopycinski, and Amanda S Graham, and Dawne K Rowe, and Michaela J Smith, and Sharon Isern, and Scott Michael, and Guido Silvestri, and Thomas H Vanderford, and Erika Castro, and Giuseppe Pantaleo, and Joel Singer, and Jill Gillmour, and Noah Kiwanuka, and Annet Nanvubya, and Claudia Schmidt, and Josephine Birungi, and Josephine Cox, and Elias K Haddad, and Pontiano Kaleebu, and Patricia Fast, and Rafick-Pierre Sekaly, and Lydie Trautmann, and Denis Gaucher
Yellow fever vaccination by scarification with 17D vaccine.
September 1958, Tropical and geographical medicine,
Enoch Muyanja, and Aloysius Ssemaganda, and Pearline Ngauv, and Rafael Cubas, and Helene Perrin, and Divya Srinivasan, and Glenda Canderan, and Benton Lawson, and Jakub Kopycinski, and Amanda S Graham, and Dawne K Rowe, and Michaela J Smith, and Sharon Isern, and Scott Michael, and Guido Silvestri, and Thomas H Vanderford, and Erika Castro, and Giuseppe Pantaleo, and Joel Singer, and Jill Gillmour, and Noah Kiwanuka, and Annet Nanvubya, and Claudia Schmidt, and Josephine Birungi, and Josephine Cox, and Elias K Haddad, and Pontiano Kaleebu, and Patricia Fast, and Rafick-Pierre Sekaly, and Lydie Trautmann, and Denis Gaucher
Antibody response to 17D yellow fever vaccine in Ghanaian infants.
January 2001, Bulletin of the World Health Organization,
Enoch Muyanja, and Aloysius Ssemaganda, and Pearline Ngauv, and Rafael Cubas, and Helene Perrin, and Divya Srinivasan, and Glenda Canderan, and Benton Lawson, and Jakub Kopycinski, and Amanda S Graham, and Dawne K Rowe, and Michaela J Smith, and Sharon Isern, and Scott Michael, and Guido Silvestri, and Thomas H Vanderford, and Erika Castro, and Giuseppe Pantaleo, and Joel Singer, and Jill Gillmour, and Noah Kiwanuka, and Annet Nanvubya, and Claudia Schmidt, and Josephine Birungi, and Josephine Cox, and Elias K Haddad, and Pontiano Kaleebu, and Patricia Fast, and Rafick-Pierre Sekaly, and Lydie Trautmann, and Denis Gaucher
Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection.
October 1998, Journal of medical virology,
Copied contents to your clipboard!